By Professor Michael Grimm

Journal articles

Chin BW; Grimm MC; Connor SJ; Leong RW, 2006, 'Managing inflammatory bowel disease', Medicine Today, 7, pp. 14 - 23

Ng WW; Lloyd AR; Grimm M, 2006, 'Appendicitis protects against colitis: an exploration of immune mechanisms', Journal of Gastroenterology and Hepatology, 21, pp. A263 - A263

McNeil HP; Grimm M, 2005, 'Achieving equal standards in medical student education: is a national exit examination the answer?', Medical Journal of Australia, 183, pp. 166 - 167

Jackson NE; Tedla NT; Geczy C; Collins AM; Grimm M; Hampartzoumian T; Hunt JE; Wang H; McNeil HP, 2005, 'IL-15 induces mast cell migration via a pertussis toxin-sensitive receptor', European Journal of Immunology, 35, pp. 2376 - 2385

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294

Grimm M; Pavli P, 2004, 'NOD2 mutations and Crohn`s disease: are Paneth cells and theirantimicrobial peptides the link?', Gut, 53, pp. 1558 - 1560

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990

Wolfrum S; Grimm M; Heidbreder M; Dendorfer A; Katus HA; Liao JK; Richardt G, 2003, 'Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme a reductase inhibitor is mediated by endothelial nitric oxide synthase', Journal of Cardiovascular Pharmacology, 41, pp. 474 - 480, http://dx.doi.org/10.1097/00005344-200303000-00017

Grimm M; Newman R; Hassim Z; Cuan N; Connor SJ; Wang J; Oppenheim JJ; Lloyd AR, 2003, 'Vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors', Journal of Immunology, 171, pp. 4990 - 4994

Grimm M; Spiecker M; De Caterina R; Shin WS; Liao JK, 2002, 'Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants', Journal of Biological Chemistry, 277, pp. 26460 - 26467, http://dx.doi.org/10.1074/jbc.M110538200

Grimm M, 2002, 'Inflammatory bowel disease and inflammatory molecules: chicken, eggs and therapeutic targets', Journal of Gastroenterology and Hepatology, 17, pp. 935 - 937

Jain D; Grimm M; Bartels C; Bechtel M; Tölg R; Hartmann F; Katus HA; Sievers HH; Richardt G, 2001, 'Early post-operative haemodynamic and neurohumoral follow-up after endoaneurysmorrhaphy', Journal of Clinical and Basic Cardiology, 4, pp. 165 - 167

Grimm M; Kurz T; Schwarz M; Richardt D; Schäfer U; Katus HA; Richardt G, 2001, 'Presynaptic regulation of cardiac norepinephrine release in ischemia', Journal of Cardiovascular Pharmacology, 38, pp. 58 - 68, http://dx.doi.org/10.1097/00005344-200107000-00007

Salley J; Grimm M; Sismanis A; Spencer RF; Wise CM, 2001, 'Methotrexate in the management of immune mediated cochleovestibular disorders: Clinical experience with 53 patients', Journal of Rheumatology, 28, pp. 1037 - 1040

Connor SJ; Grimm MC, 2001, 'Heparin as an anti-inflammatory agent: It's no GAG to forget about chemokines [3]', Gut, 48, pp. 738, http://dx.doi.org/10.1136/gut.48.5.738

Mortimore M; Gibson PR; Selby WS; Radford-Smith GL; Florin THJ; Ooi K; Wood L; Macrae F; Lachal S; Connell W; Crotty B; Griffin S; Grimm M; James S; Katelaris P; Pavli P, 2001, 'Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-α, in the treatment of Crohn's disease: Is its efficacy augmented by steroid-sparing immunosuppressive therapy?', Internal Medicine Journal, 31, pp. 146 - 150, http://dx.doi.org/10.1046/j.1445-5994.2001.00039.x

Grimm MC, 2001, 'Inflammatory bowel disease - Genes, germs and the gastrointestinal immune system', Today's Life Science, 13, pp. 24 - 30

Takemoto M; Node K; Nakagami H; Liao Y; Grimm M; Takemoto Y; Kitakaze M; Liao JK, 2001, 'Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy', Journal of Clinical Investigation, 108, pp. 1429 - 1437, http://dx.doi.org/10.1172/JCI13350

Zotz RJ; Zirlik A; Raeder T; Hahn M; Binner C; Ullmann C; Grimm M; Schuler G, 2001, 'Three-dimensional visualization of coronary arteries in excised hearts', Journal of the American Society of Echocardiography, 14, pp. 11 - 19, http://dx.doi.org/10.1067/mje.2001.110781

Amansec SG; Connor SJ; Cardillo R; Cuan N; Grimm MC; Conway P, 2001, 'AMELIORATION OF MURINE TNBS COLITIS USING PREBIOTICS', Journal of Gastroenterology and Hepatology, 16, pp. 6 - 6, http://dx.doi.org/10.1111/j.1440-1746.2001.ca01-6.x

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0

Dalhoff K; Kothe H; Grimm M; Katus HA; Katus HA, 2000, 'Inflammation, CSE-Hemmer und Chlamydia pneumoniae Inflammation, Statins and Chlamydia pneumoniae', Herz Kreislauf, 32, pp. 123 - 125

Cardillo R; Hassim Z; Tedla N; Lloyd AR; Grimm MC, 2000, 'VIP desensitizes chemokine receptors and impairs leukocyte trafficking and inflammation in vivo.', GASTROENTEROLOGY, 118, pp. A357 - A357, http://dx.doi.org/10.1016/S0016-5085(00)83531-3

Richardt G; Grimm M; Haass M, 2000, 'Sympathetic nerves and coronary heart disease', Deutsche Medizinische Wochenschrift, 125, pp. 159 - 164, http://dx.doi.org/10.1055/s-2007-1023991

Davenport MP; Grimm MC; Lloyd AR, 2000, 'A homing selection hypothesis for T-cell trafficking', Immunology Today, 21, pp. 315 - 317

Davenport ; Grimm M; Lloyd DH, 2000, 'A homing seletion hypothesis for T-cell trafficking', Immunology Today, pp. 315 - 317

Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Wang JM, 1999, 'Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4⁺ T cells', Journal of Immunology, 162, pp. 7128 - 7132

Su SB; Gong WH; Gao JL; Shen WP; Grimm MC; Deng X; Murphy PM; Oppenheim JJ; Wang JM, 1999, 'T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor', Blood, 93, pp. 3885 - 3892, http://dx.doi.org/10.1182/blood.v93.11.3885.411k19_3885_3892

Su SB; Gong W-H; Gao J-L; Shen W-P; Grimm MC; Deng X; Murphy PM; Oppenheim JJ; Wang JM, 1999, 'T20/DP178, an Ectodomain Peptide of Human Immunodeficiency Virus Type 1 gp41, Is an Activator of Human Phagocyte N-Formyl Peptide Receptor', Blood, 93, pp. 3885 - 3892, http://dx.doi.org/10.1182/blood.v93.11.3885

Grimm MC; Hassim Z; Lloyd AR; Oppenheim JJ, 1999, 'Chemokine receptors are inhibited by vasoactive intestinal peptide: Desensitization of HIV-1 co-receptors', GASTROENTEROLOGY, 116, pp. A728 - A728, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079778403161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Biragyn A; Tani K; Grimm MC; Weeks S; Kwak LW, 1999, 'Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity', Nature Biotechnology, 17, pp. 253 - 258, http://dx.doi.org/10.1038/6995

Powell L; Selby W; McCaughan G; Grimm MC, 1999, 'Fifty years of gastroenterology in Australia', Journal of Gastroenterology and Hepatology (Australia), 14, pp. 179 - 193, http://dx.doi.org/10.1046/j.1440-1746.1999.01825.x

Su SB; Ueda H; Howard OMZ; Grimm MC; Gong W; Ruscetti FW; Oppenheim JJ; Wang JM, 1999, 'Inhibition of the expression and function of chemokine receptors on human CD4+ leukocytes by HIV-1 envelope protein gp 120', Chemical Immunology, 72, pp. 141 - 160, http://dx.doi.org/10.1159/000058731

Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OMZ; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ, 1999, 'Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells. In vivo neovascularization induced by stromal-derived factor-1α', American Journal of Pathology, 154, pp. 1125 - 1135, http://dx.doi.org/10.1016/S0002-9440(10)65365-5

Wang JM; Ueda H; Howard OMZ; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ, 1998, 'HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation', Journal of Immunology, 161, pp. 4309 - 4317

Ueda H; Howard OMZ; Grimm MC; Su SB; Gong W; Evans G; Ruscetti FW; Oppenheim JJ; Wang JM, 1998, 'HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes', Journal of Clinical Investigation, 102, pp. 804 - 812, http://dx.doi.org/10.1172/JCI3273

Grimm MC; Ben-Baruch A; Taub DD; Howard OMZ; Resau JH; Wang JM; Ali H; Richardson R; Snyderman R; Oppenheim JJ, 1998, 'Opiates transdeactivate chemokine receptors: δ and μ opiate receptor- mediated heterologous desensitization', Journal of Experimental Medicine, 188, pp. 317 - 325, http://dx.doi.org/10.1084/jem.188.2.317

Gong W; Howard OMZ; Turpin JA; Grimm MC; Ueda H; Gray PW; Raport CJ; Oppenheim JJ; Wang JM, 1998, 'Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5- mediated HIV-1 entry/replication', Journal of Biological Chemistry, 273, pp. 4289 - 4292, http://dx.doi.org/10.1074/jbc.273.8.4289

Ben-Baruch A; Grimm M; Bengali K; Evans GA; Chertov O; Wang JM; Howard OMZ; Mukaida N; Matsushima K; Oppenheim JJ, 1997, 'The Differential Ability of IL-8 and Neutrophil-Activating Peptide-2 to Induce Attenuation of Chemotaxis Is Mediated by Their Divergent Capabilities to Phosphorylate CXCR2 (IL-8 Receptor B)', Journal of Immunology, 158, pp. 5927 - 5933

Grimm MC; Doe WF, 1996, 'Chemokines in inflammatory bowel disease mucosa: Expression of RANTES, Macrophage Inflammatory Protein (MIP)-1α, MIP-1β, and γ-interferon-inducible protein-10 by macrophages, lymphocytes, endothelial cells, and granulomas', Inflammatory Bowel Diseases, 2, pp. 88 - 96, http://dx.doi.org/10.1002/ibd.3780020204

Grimm MC; Elsbury SKO; Pavli P; Doe WF, 1996, 'Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa', Journal of Leukocyte Biology, 59, pp. 804 - 812, http://dx.doi.org/10.1002/jlb.59.6.804

Pavli P; Cavanaugh J; Grimm M, 1996, 'Inflammatory bowel disease: Germs or genes?', Lancet, 347, pp. 1198, http://dx.doi.org/10.1016/S0140-6736(96)90727-8

Grimm MC; Elsbury SKO; Pavli P; Doe WF, 1996, 'Interleukin 8: Cells of origin in inflammatory bowel disease', Gut, 38, pp. 90 - 98, http://dx.doi.org/10.1136/gut.38.1.90

GRIMM M; PULLMAN W; BENNETT G; SULLIVAN P; PAVLI P; DOE W, 1995, 'Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa', Journal of Gastroenterology and Hepatology, 10, pp. 387 - 395, http://dx.doi.org/10.1111/j.1440-1746.1995.tb01589.x

Grimm MC; Pavli P; Van de Pol E; Doe WF, 1995, 'Evidence for a CD14⁺ population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis', Clinical and Experimental Immunology, 100, pp. 291 - 297, http://dx.doi.org/10.1111/j.1365-2249.1995.tb03667.x

Conference Papers

Tavakoli P; Vollmer-Conna U; Campos XV; Hadzi-Pavlovic D; Grimm M, 2020, 'Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S296 - S297, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518803401188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Su SB; Gong WH; Gao JL; Shen WP; Grimm MC; Murphy PM; Oppenheim JJ; Wang JM, 1999, 'T20/DP 178, an ectodomain peptide of HIV-1 gp41, is a potent activator of human phagocyte N-formyl peptide receptor', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A293 - A293, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082033301689&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grimm MC; Ben-Baruch A; Taub DD; Howard OMZ; Wang JM; Oppenheim JJ, 1998, 'Opiate inhibition of chemokine-induced chemotaxis', in Annals of the New York Academy of Sciences, pp. 9 - 20, http://dx.doi.org/10.1111/j.1749-6632.1998.tb09544.x

Howard OMZ; Korte T; Tarasova NI; Grimm M; Turpin JA; Rice WG; Michejda CJ; Blumenthal R; Oppenheim JJ, 1998, 'Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor- mediated function', in Journal of Leukocyte Biology, pp. 6 - 13, http://dx.doi.org/10.1002/jlb.64.1.6

Back to profile page